BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$57.18
Tradestie Score
46
Market Cap
$10.53B
P/E Ratio
157.9
Revenue Growth
0.2%
Analyst Upside
+60.2%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.87
|
$12.36B | 17.9 | 66 | Compare |
|
EXEL
Exelixis Inc
|
$58.39
|
$11.09B | 18.2 | 43 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.72
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$190.01
|
$10.74B | - | 35 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$43.54
|
$10.49B | - | 71 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.25
|
$10.22B | - | 76 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$499.40
|
$10.01B | - | 54 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.40
|
$9.33B | 62.4 | 62 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$116.23
|
$8.88B | 259.1 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$109.86
|
$8.77B | 32.4 | 54 | Compare |
More BMRN Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry